ABSTRACT Bronchograms and computed tomograms were performed in 27 patients who presented consecutively for bronchography with chronic sputum production. The films were reported separately by three consultant radiologists, who had been asked to give a diagnostic interpretation of the films for each bronchopulmonary segment. The reporting of bronchiectasis on computed tomograms was compared with that on bronchograms. The sensitivity and specificity of computed tomography at segmental level compared with bronchography was 66% and 92%, respectively. We conclude that computed tomography alone is not yet suitable for accurate characterisation and localisation of disease in patients in whom surgery is contemplated. Computed tomography may be useful in patients in whom bronchography is contraindicated and for monitoring progression of disease after initial combined computed tomography and bronchography.
Bronchography has been used for many years as a definitive investigation to identify the presence, severity, and extent of bronchial abnormalities, particularly bronchiectasis, but it is an invasive investigation and unpleasant for the patient. Despite refinements in technique and contrast medium, complications may occur, which include allergic and foreign body reaction to the contrast medium, pulmonary infection, and a temporary reduction in pulmonary function with impaired ventilation and diffusion.' Bronchiectasis, as the term is used in this study, is permanent, irreversible dilatation of the bronchial tree, and its features as seen by the newer technique of computed tomography (CT) have been described by Naidich et al.2 Mootoosamy et al recently concluded that CT was useful in assessing bronchiectasis,3 but Muller et al, on the other hand, found it unreliable in diagnosing cylindrical and varicose bronchiectasis.4
In view of the apparent conflict in current reports, we conducted a controlled study to assess the sensitivity and specificity of CT compared with bronchography in the diagnosis of bronchiectasis.
Patients and methods

PATIENTS
Twenty seven patients who presented consecutively for bronchography with symptoms of cough and sputum were studied. Of these, 26 expectorated sputum daily (median duration eight years) and the sputum in 24 was purulent; one expectorated sputum intermittently. All but one of the patients were examined more than three months after an exacerbation, the exception having a repeat CT scan three months later; only the second scan was included in the analysis.
INVESTIGATIONS
CT preceded bronchography in 24 patients; in the other three, CT followed bronchography by four to six weeks. The CT scans were performed on an Elscint 2002 scanner with a five second scanning time and 512 x 512 matrix. All patients were scanned supine, using a standard protocol, in full suspended inspiration from lung apex to diaphragm in 10mm increments with a 10mm slice width. The optimum window width for visualising the bronchi was found to be 1400 to 1600 Hounsfield units (HU) with a centre of -600 HU.
The CT scans were initially read by two pulmonary radiologists, who were asked to provide a general diagnostic interpretation of the scans for each seg-Role of computed tomography in diagnosis of bronchiectasis ment, and to report on the presence or absence of five features for each segment-namely, proximal bronchial dilatation, distal bronchial dilatation, proximal bronchial wall thickening, distal bronchial wall thickening, and parenchymal shadowing.
Bronchography was performed in all 27 patients and each investigation preceded by a plain chest radiograph. The contrast was introduced into the lungs through a fibreoptic bronchoscope in 15 patients and a nasal catheter in 12. Twenty three examinations were bilateral and four unilateral. The contrast agent used was an aqueous suspension of propyliodone (Dionosil Aqueous, Glaxo).
The bronchograms were assessed by two pulmonary radiologists for the presence or absence of proximal bronchial dilatation, distal bronchial dilatation, non-tapering of the bronchi, lack of filling of bronchial side branches, and presence of excess mucus (luminal filling defects). In addition, a diagnostic interpretation was reported for each segment (fig 1) .
The radiologists were aware only that all patients had chronic sputum production. The patients' identity was concealed when the bronchograms and CT scans were reported. The two investigations were reported separately and in random order by both radiologists independently. A third radiologist assessed the bronchograms and CT scans in a similar manner but only recorded a diagnostic interpretation.
For each patient the plain chest radiograph was assessed for the presence of linear markings, "bronchial wall thickening", patchy or confluent pulmonary shadowing, pleural thickening, evidence of lung collapse or volume loss, and circular markings as described by Gudbjerg.5 In addition, the radiologists were asked to assess the presence or absence of bronchiectasis. 
ANALYSIS
The diagnostic interpretations of all three radiologists were considered in the comparison of CT scans and bronchograms for each of the 448 segments. Bronchiectasis was defined as being present if it was reported by either two or three of the radiologists. Conversely, if only one or none of the radiologists reported bronchiectasis the segment was defined as non-bronchiectatic.
Bronchography was regarded as the "gold standard" against which CT was judged as it is the accepted method for diagnosing bronchiectasis. The sensitivity, false negative rate, specificity, and false positive rate of CT for the diagnosis of bronchiectasis that had been confirmed bronchographically were calculated at segmental, lobar, and lung level. Sensitivity (%) was defined as:
True positive 100 True positive + false negative x and was calculated at segmental level as:
No of segments bronchiectactic on both CT and bronchography x 100 Total No ofsegments bronchiectactic on bronchogram The false negative (%) rate was (100 -sensitivity). Specificity (%) was defined as:
True negative . X 100
True negative and false positive and was calculated at segmental level as:
No ofsegments non-bronchiectatic on both CT and bronchography .
100
Total No ofsegments non-bronchiectatic on bronchography and the false positive (%) rate was (100 -specificity).
Similar calculations were used to derive these indices for CT at lobar and lung level. The detailed bronchographic interpretation of the abnormalities seen in the false positive segments on CT were recorded by the first two radiologists only. The correlations between CT and bronchography for the presence or absence of proximal dilatation and distal dilation were determined.
Results Table 1 shows the number of segments reported as positive for each of the five features on CT. A total of 92 segments were reported as bronchiectatic by two or three radiologists. Table 2 shows the correlation between proximal and distal bronchial dilatation as reported on both CT and bronchography. The percentage of segments reported as positive on CT for proximal dilatation and distal dilatation/non-tapering was only 56% and 52% of 274 Cooke, Currie, Morgan, Kerr, Delany, Strickland, Cole these reported as positive for each feature on bronchography. The false positive rate for these features on CT was 10% and 6%, respectively.
A total of 98 segments were reported as bronchiectatic on bronchography, but only 65 of these segments were reported as positive on CT. The sensitivity of CT in detecting bronchiectasis at a segmental level, therefore, was 66% (65/98), with a false negative rate of 34% (33/98) (fig 2a and b) . At segmental level the specificity of CT was 92% (323/350), with an 8% false positive rate (27/350) (fig 3a and 3b) . At lobar level the sensitivity was 71% (32/45) and specificity 86% (70/81), and at lung level the sensitivity was 87% (26/30) and specificity was 75% (15/20).
Bronchiectasis was reported in 27 segments on CT alone with no confirmation on bronchography. The interpretation of these segments on the bronchograms by the first two radiologists was that nine were underfilled, eight showed chronic bronchitis, four were normal, and the other six segments were reported by one of the radiologists as having bronchiectasis (two) and an unspecified bronchial abnormality (four).
The sensitivity of the plain chest x ray film for assessing bronchiectasis was only 37% (11/30) at lung level, with a 63% false negative rate compared with bronchography. The specificity was 95% (18/19), with a 5% false positive rate.
Discussion
The design of a trial to evaluate the sensitivity and specificity of CT is important. If patients are "positively" selected for CT by a bronchogram that shows bronchiectasis then a good correlation between the two investigations can be expected. A sufficient number of patients need to be examined to provide a representative sample of severity and types of bronchiectasis and other bronchial abnormalities. In our study 27 patients were studied consecutively, affording direct comparison of 50 lungs, which were separately assessed both with regard to CT and bronchography. Three pulmonary radiologists were asked to report on each investigation separately without knowledge of the results of the other investigation. If CT scan and bronchogram are performed close together and viewed simultaneously the diagnosis on CT may be influenced by the abnormalities seen on the bronchogram. The range of bronchographic abnormalities seen in our study6 varied from none (five of 50 lungs) to obvious bronchiectasis (19 lungs). Bronchographic features of both bronchiectasis and chronic bronchitis were present in 10 lungs. The bronchiectatic segments were varicose or cylindrical in all but one lung, which showed saccular (cystic) bronchiectasis. We contend that the range of abnormalities, the number of lungs studied, and the comparisons made were adequate to draw firm conclusions.
Our conclusions are similar to those of Muller et al, who analysed CT scan and bronchogram abnormalities at lobar level only but found poor correlation between the two investigations, with agreement in only six of 13 patients.4 In contrast, Mootoosamy et al found an excellent correlation between findings on CT and bronchography in their series, though there were 10 "false negative" segments on CT of 52 that showed bronchiectasis on bronchography (sensitivity 81%) and four "false positive" segments on CT of 78 that did not show bronchiectasis on bronchography (specificity 95%).3 The results of Mootoosamy et al are therefore similar to ours, though 276 their conclusion' differs from ours and those of Muller etal.4 The high specificity of CT (99%) reported by Phillips et al may reflect their method of reporting bronchograms as the radiologist was asked to make a definite decision about whether bronchiectasis was present or not and no allowance was made for the bronchial abnormalities seen in patients with chronic bronchitis, who, we suspect, were labelled as bronchiectatic.7 These authors' concluded that the sensitivity of CT (79%) was relatively poor.
Computed tomography seems to be less sensitive for diagnosing bronchiectasis than bronchography. In bronchography contrast medium outlines the lumen of each bronchus, allowing its width to be directly visualised and, with adequate filling, the calibre of the terminal bronchus to be judged. In CT assessment of bronchial dilatation depends on visualisation of the bronchial walls. With proximal bronchi, the walls are easily visible so that dilatation can be evaluated, though it is seen more easily in bronchi that run in the plane of the scan rather than in those that run axially. Distal bronchi with normal wall thickness cannot be seen with current computed tomographic scanners so that distal dilatation cannot be judged easily and bronchial walls need to be thickened to be visible.
The caution necessary in diagnosing bronchiectasis on CT, as it is a new technique, will also tend to reduce its sensitivity. There were a similar number of false positive and false negative diagnoses on CT, so that although a less conservative approach to the diagnosis of bronchiectasis on CT may improve the sensitivity, it would be offset by a reduction in specificity. A new technique for pulmonary CT has been described that incorporates a 3mm slice width (rather than the conventional 8 mm or 1Omm) with a different computer algorithm to produce sharper, clearer images.8 This "thin section" scan has not been evaluated critically with respect to lung diseases, but its usefulness in bronchiectasis has been implied.
The specificity of CT calculated at segmental level (92%) is high and largely reflects the high frequency of normal segments on both CT and bronchography in the upper lobes (excluding the lingula). We consider the specificity at lung level (75%) to be a more appropriate judge of CT.
The meaning of the abnormalities in the 27 segments diagnosed as bronchiectatic on CT alone is unknown. Fourteen were regarded as abnormal on the bronchogram and eight were reported by two or three radiologists as showing features of chronic bronchitis. Nine other segments, all in one patient, were underfilled, leaving the possibility that bronchographic bronchiectasis was missed in some of these segments.
Although bronchography has been accepted as the Cooke, Currie, Morgan, Kerr, Delany, Strickland, Cole established radiological method for diagnosing bronchiectasis, we have shown that two experienced radiologists found difficulty in some cases in differentiating between mild cylindrical bronchiectasis and chronic bronchitis.6 Clinical, bronchographic, and pathological similarities between these conditions are known to exist.6 9 There is possibly similar overlap of abnormal features on CT and this investigation may identify a different subgroup of abnormal bronchi present in patients with chronic sputum production.
The plain chest radiograph was less sensitive than CT but was very specific. A chest radiograph with extensive abnormalities diagnostic of bronchiectasis will be adequate to assess only a small proportion of patients with chronic sputum production. CT will identify more areas of bronchiectasis than a plain chest radiograph, but bronchography remains the definitive investigation for diagnosis of bronchiectasis in view of the poor sensitivity and significant false positive rate of CT. CT does have a place, however, in assessing patients with chronic sputum production who are unfit for, or refuse, bronchography and, if disease is identified, may aid in patient positioning during postural drainage and physiotherapy. It may be valuable, in combination with an initial bronchogram, in monitoring disease progression. If more accurate characterisation and localisation of disease is required for patients in whom surgery is considered CT alone is inadequate and bronchography should be performed. CT has the advantage of not being confined by historical terminology, which often restricts the radiologist to a differential diagnosis of chronic bronchitis or bronchiectasis on bronchography. As CT outlines different features from those seen on bronchography it may help us to understand the different types of disease and their natural histories in patients with sputum production, particularly if CT appearances are correlated with pathological features.
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